Literature DB >> 12622411

Novel protein kinases in pancreatic cell growth and cancer.

Thomas Seufferlein1.   

Abstract

The network of enzymes that contribute to the signal transduction of extracellular factors in pancreatic cancer is ever increasing. The classical Raf-MEK-ERK signaling cascade plays a crucial role in the regulation of apoptosis, proliferation, and metastasis of pancreatic cancer. Phosphatidylinositide-3-kinase also contributes to growth and prevents apoptosis in pancreatic cancer cells, acting in part via its downstream targets, PKB/AKT and the FRAP/p70s6k signaling complex. Recently, members of the PKC family of serine threonine kinases have emerged as novel modulators of transformation and cell cycle progression of pancreatic cancers. The novel PKD family of serine threonine kinases has just been detected in pancreatic cancer and awaits its functional characterization in these tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12622411     DOI: 10.1385/IJGC:31:1-3:15

Source DB:  PubMed          Journal:  Int J Gastrointest Cancer        ISSN: 1537-3649


  34 in total

1.  4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase.

Authors:  S R von Manteuffel; A C Gingras; X F Ming; N Sonenberg; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

2.  The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth.

Authors:  D Rousseau; A C Gingras; A Pause; N Sonenberg
Journal:  Oncogene       Date:  1996-12-05       Impact factor: 9.867

3.  Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.

Authors:  Markus Guba; Philipp von Breitenbuch; Markus Steinbauer; Gudrun Koehl; Stefanie Flegel; Matthias Hornung; Christiane J Bruns; Carl Zuelke; Stefan Farkas; Matthias Anthuber; Karl-Walter Jauch; Edward K Geissler
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

4.  Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration.

Authors:  K Giehl; B Skripczynski; A Mansard; A Menke; P Gierschik
Journal:  Oncogene       Date:  2000-06-08       Impact factor: 9.867

5.  Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma.

Authors:  M P Lutz; I B Esser; B B Flossmann-Kast; R Vogelmann; H Lührs; H Friess; M W Büchler; G Adler
Journal:  Biochem Biophys Res Commun       Date:  1998-02-13       Impact factor: 3.575

6.  Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.

Authors:  J Q Cheng; B Ruggeri; W M Klein; G Sonoda; D A Altomare; D K Watson; J R Testa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 7.  [Rapamycin and CCI-779].

Authors:  J Alexandre; E Raymond; J P Armand
Journal:  Bull Cancer       Date:  1999-10       Impact factor: 1.276

8.  FRAP-p70s6K signaling is required for pancreatic cancer cell proliferation.

Authors:  S A Shah; M W Potter; R Ricciardi; R A Perugini; M P Callery
Journal:  J Surg Res       Date:  2001-05-15       Impact factor: 2.192

9.  Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells.

Authors:  M S Tsao; S Chow; D W Hedley
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

10.  Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase.

Authors:  D J Price; J R Grove; V Calvo; J Avruch; B E Bierer
Journal:  Science       Date:  1992-08-14       Impact factor: 47.728

View more
  8 in total

1.  Understanding the stereospecific interactions of 3-deoxyphosphatidylinositol derivatives with the PTEN phosphatase domain.

Authors:  Qin Wang; Yang Wei; Madhusoodanan Mottamal; Mary F Roberts; Goran Krilov
Journal:  J Mol Graph Model       Date:  2010-05-20       Impact factor: 2.518

2.  Purinergic receptors in the endocrine and exocrine pancreas.

Authors:  I Novak
Journal:  Purinergic Signal       Date:  2007-12-11       Impact factor: 3.765

3.  Graviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolism.

Authors:  María P Torres; Satyanarayana Rachagani; Vinee Purohit; Poomy Pandey; Suhasini Joshi; Erik D Moore; Sonny L Johansson; Pankaj K Singh; Apar K Ganti; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-04-01       Impact factor: 8.679

4.  Insights into the structural specificity of the cytotoxicity of 3-deoxyphosphatidylinositols.

Authors:  Yanling K Wang; Wei Chen; Derek Blair; Mingming Pu; Yingju Xu; Scott J Miller; Alfred G Redfield; Thomas C Chiles; Mary F Roberts
Journal:  J Am Chem Soc       Date:  2008-05-23       Impact factor: 15.419

5.  In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenografts.

Authors:  Jianxia Guo; Dana M Clausen; Jan H Beumer; Robert A Parise; Merrill J Egorin; Karla Bravo-Altamirano; Peter Wipf; Elizabeth R Sharlow; Qiming Jane Wang; Julie L Eiseman
Journal:  Cancer Chemother Pharmacol       Date:  2012-10-30       Impact factor: 3.333

6.  Protein kinase D1 mediates anchorage-dependent and -independent growth of tumor cells via the zinc finger transcription factor Snail1.

Authors:  Tim Eiseler; Conny Köhler; Subbaiah Chary Nimmagadda; Arsia Jamali; Nancy Funk; Golsa Joodi; Peter Storz; Thomas Seufferlein
Journal:  J Biol Chem       Date:  2012-07-12       Impact factor: 5.157

7.  Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinases.

Authors:  Christoph Wille; Conny Köhler; Milena Armacki; Arsia Jamali; Ulrike Gössele; Klaus Pfizenmaier; Thomas Seufferlein; Tim Eiseler
Journal:  Mol Biol Cell       Date:  2013-12-11       Impact factor: 4.138

8.  Protein Kinase D family kinases: roads start to segregate.

Authors:  Christoph Wille; Thomas Seufferlein; Tim Eiseler
Journal:  Bioarchitecture       Date:  2014-05-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.